The most important financial indicators for the company Clinical Research Srl - Unique Identification Number 35162080:
sales in 2023 was
336.669
euro, registering a net profit of
259.616
euro and having an average number of
employees.
Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in biotehnologie having the NACE code 7211.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -13.6%, from 390.761 euro in the year 2022, to 336.669 euro in 2023.
The Net Profit decreased by -73.110 euro, from 333.739 euro in 2022, to 259.616 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Clinical Research Srl - CUI 35162080
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
998
36.899
2.210
77.433
56.597
40.359
41.354
138.800
96.964
Current Assets
-
3.698
3.762
43.056
155.226
111.685
228.863
208.936
192.245
167.539
Inventories
-
1.560
707
0
0
0
0
0
0
0
Receivables
-
0
0
205
30.759
12.834
151.027
125.846
187.895
151.100
Cash
-
2.138
3.055
42.851
124.467
98.851
77.835
83.091
4.350
16.438
Shareholders Funds
-
1.067
16.858
45.219
224.533
167.881
263.405
240.223
333.783
259.661
Social Capital
-
45
45
44
43
42
41
40
41
40
Debts
-
3.629
23.940
156
10.884
5.725
8.844
12.547
2.273
10.270
Income in Advance
-
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"7211 - 7211"
CAEN Financial Year
7211
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
167.539 euro in 2023 which includes Inventories of
0 euro, Receivables of
151.100 euro and cash availability of
16.438 euro.
The company's Equity was valued at
259.661 euro, while total Liabilities amounted to
10.270 euro.
Equity decreased by -73.110 euro, from 333.783 euro in 2022, to 259.661 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Clinical Research Srl